Cargando…
Risk Factors of Hyperammonemia in Patients With Epilepsy Under Valproic Acid Therapy
Hyperammonemia has been reported to be associated with patients who receive valproic acid (VPA) therapy. This study aimed to determine the risk factors for hyperammonemia in patients with epilepsy treated with VPA. One hundred and fifty-eight adult patients with epilepsy aged older than 17 years who...
Autores principales: | Tseng, Yu-Lung, Huang, Chi-Ren, Lin, Chih-Hsiang, Lu, Yan-Ting, Lu, Cheng-Hsien, Chen, Nai-Ching, Chang, Chiung-Chih, Chang, Wen-Neng, Chuang, Yao-Chung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616274/ https://www.ncbi.nlm.nih.gov/pubmed/25192484 http://dx.doi.org/10.1097/MD.0000000000000066 |
Ejemplares similares
-
Hyperammonemia Associated with Valproic Acid Concentrations
por: Vázquez, Marta, et al.
Publicado: (2014) -
Clinical significance of serological biomarkers and neuropsychological performances in patients with temporal lobe epilepsy
por: Chang, Chiung-Chih, et al.
Publicado: (2012) -
Ultrasonographic median nerve cross-section areas measured by 8-point "inching test" for idiopathic carpal tunnel syndrome: a correlation of nerve conduction study severity and duration of clinical symptoms
por: Chen, Shu-Fang, et al.
Publicado: (2011) -
Ultrasonographic assessment of carpal tunnel syndrome of mild and moderate severity in diabetic patients by using an 8-point measurement of median nerve cross-sectional areas
por: Chen, Shu-Fang, et al.
Publicado: (2012) -
Risk of Microangiopathy in Patients with Epilepsy under Long-term Antiepileptic Drug Therapy
por: Chen, Nai-Ching, et al.
Publicado: (2018)